Prolonged islet allograft acceptance in the absence of interleukin 4 expression

Transplant Immunology

Volumn 4, Issue 1, 1996, Pages 81-85

  Nickerson, Peter ^b   Zheng, Xin Xiao ^f   Steiger, Jürg ^c   Steele, Alan W ^d   Steurer, Wolfgang ^e   Roy Chaudhury, Prabir ^f   Müller, Werner ^f   Strom, Terry B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^e Abt f Transplantationschirugie   (Austria)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HYBRID PROTEIN; INTERLEUKIN 4;

ANIMAL TISSUE; CONFERENCE PAPER; IMMUNOLOGICAL TOLERANCE; MALE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0029886947     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80043-8     Document Type: Conference Paper

References (30)

1. O'Connell PJ, Pacheco-Silva A, Nickerson PW et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
2. Takeuchi T, Lowry RP, Konieczny B. Heart allografts in murine systems: the differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 1992; 53: 1281.
3. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
4. Lipman ML, Stevens AC, Strom TB. Heightened intragraft cytotoxic T lymphocyte gene expression in acutely rejecting renal allografts. J Immunol 1994; 152: 5120.
5. Nickerson PW, Pacheco-Silva A, O'Connell PJ et al. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction. Transplant Proc 1993; 25: 984.
6. Bugeon J-P, Cuturi M-C, Hallet M-M, Paineau J, Chabannes D, Soulillou J-P. Peripheral tolerance of an allograft in adult rats - characterization by low interleukin-2 and interferon-γ mRNA levels and by strong accumulation of major histocompatibility complex transcripts in the graft. Transplantation 1992; 54: 219.
7. Hancock WW, Sayegh MH, Kwok CA, Weiner HL, Carpenter CB. Oral, but not intravenous, alloantigen prevents accelerated allograft rejection by selective intragraft Th2 cell activation. Transplantation 1993; 55: 219.
8. Kupiee-Weglinski JW, Wasowska B, Papp I et al. CD4 mAb therapy modulates alloantibody production and intracardiac graft deposition in association with selective inhibition of Th1 lymphokines. J Immunol 1993; 151: 5053.
9. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76: 241.
10. Lowry RP. The relationship of IL-4, IL-10, and other cytokines to transplantation tolerance. Transplant Sci 1993; 3: 104.
11. Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance. J Immunol 1995; 155: 1165.
12. Kuhn R, Ragewski K, Muller W. Generation and analysis of interleukin-4 deficient mice. Science 1991; 254: 707.
13. Gotoh M, Maki T, Satomi S. Porter J, Monaco AP. Immmunological characteristics of purified pancreatic islet grafts. Transplantation 1986; 42: 387.
14. Bogen SA, Fogelman I, Abbas AK. Analysis of IL-2, IL-4 and IFNγ producing cells in situ during immune responses to protein antigens. J Immunol 1993: 150: 4197.
15. Flamand V, Abramowicz D, Goldman M. et al. Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo. J Immunol 1990, 144: 2875.
16. Turka I.A, Linsley PS, Lin H et al. T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci USA 1992; 89: 11102.
17. Knauf MJ, Bell DP, Hirtzer P, Luo Z-P, Young JD, Katre NV. Relationship of effective molecular size to systemic clearance in rats of recombinant interleukin-2 chemically modified with water soluble polymers. J Biol Chem 1988; 263: 15064.
18. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ, Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
19. Tan P, Anasetti C, Hansen JA et al. Induction of alloantigen-specific hyporesponsiveness in human T lymphncytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med 1993; 177: 165.
20. Paul WE, Ohara J. B-cell stimulatory factor- 1/interleukin 4. Annu Rev Immunol 1987; 5: 429.
21. Stack RM, Lenschow DJ, Gray GS, Bluestone JA, Fitch FW. IL-4 treatment of small splenic B cells induces costimulatory molecules B7-1 and B7-2. J Immunol 1994; 152: 5723.
22. Hiester AA, Metcalf DR. Campbel PA. Interleukin-4 is chemotactic for mouse macrophages. Cell Immunol 1992; 139: 72.
23. Masinovsky B, Urdal D, Gallatin WM. IL-4 acts synergistically with IL-1b to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1. J Immunol 1990; 145: 2886.
24. Thornhill MH, Wellicome SM, Mahiouz DL. Lanchbury JS, Kyan-Aung U, Haskard DO. Tumor necrosis factor combines with IL-4 or IFNγ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J Immunol 1991; 146: 592.
25. Piela-Smith TH, Broketa G, Hand A, Korn JH. Regulation of ICAM-1 expression and function in human dermal fibroblasts by IL-4. J Immunol 1992; 148: 1375.
26. Widmer MB, Voice RF, Conlon PJ, Grabstein KH. Precursor frequency and lytic specificity of interleukin 2 and interleukin 4-responsive murine lymphocytes. Transplantation 1990; 49: 743.
27. Spits H, Yssel Y, Paliard X, Kastelein R, Figdor C, de Vries JE. IL-4 inhibits Il-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures. J Immunol 1988; 141: 29.
28. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of non-cytolytic IL-10/Fc in murine models of LPS-induced septic shock and allogeneic islet transplantation. J Immunol 1995 (in press).
29. Chen WF, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528.
30. te Velde AA, Malefijt RdW, Huijbens RJF, de Vries JE, Figdor CG. IL-10 stimulates monocyte FcγR surface expression and cytotoxic activity. 1992, 1992; 149: 4048.